Key facts
- CaTe’s last known valuation is $20.9M (Dec 2025).
- It has raised $16.1M; the latest was Later Stage VC ($11.1M) in Dec 2025.
- Notable investors include Mitsubishi UFJ Capital, Mizuho Capital, JIC Venture Growth Investments, Mirai Creation Capital, Coral Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for CaTe
- ·The full record, as it builds
Funding rounds
No funding rounds for CaTe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CaTe
Developer of an application for cardiac rehabilitation treatment designed to connect people with IoT and artificial intelligence to improve medical care. The company uses IoT and AI technologies to improve the delivery of medical care and educational services and is equipped with functions that promote behavioural changes, such as daily vital data sharing, lifestyle diet management, AI notifications and chat functions, enabling users and the healthcare sector to perform outpatient cardiac rehabilitation and improve their standard of living.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2020
- Website
- cate.co.jp/
- Ownership
- Privately Held (backing)
CaTe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CaTe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CaTe in its N-PORT filings yet. We sweep new filings monthly.